Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
08/2007
08/07/2007US7253007 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
08/07/2007CA2190256C Process for preparing aromatic or heteroaromatic sulfonyl halides
08/02/2007WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007070760A3 Compounds which modulate the cb2 receptor
08/02/2007US20070179155 N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
08/02/2007CA2636931A1 Piperazines and piperidines as mglur5 potentiators
08/01/2007EP1812410A2 Indinavir derivatives useful in immunoassay
08/01/2007EP1812407A2 Novel compounds of substituted and unsubstituted adamantyl amides
08/01/2007EP1812008A1 Il-8 receptor antagonists
08/01/2007EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/01/2007EP1187592B1 Alpha v integrin receptor antagonists
08/01/2007CN1329386C Substituted phenylacetamides and their use as glucokinase activators
08/01/2007CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders
08/01/2007CN101010305A Catalysis of diketopiperazine synthesis
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/01/2007CN101007786A 2[(3-phenyl) acrylketony]-3-methylquinoxaline chemical synthesis method
08/01/2007CN101007785A 2[(3-phenyl) acrylketone]-3-methylquinoxaline chemical synthesis method
07/2007
07/31/2007USRE39754 Benzamide derivatives and pharmaceutical compositions containing same
07/31/2007US7250511 intermediates in the preparation of derivatives which possess anti-cancer activity; synthesis of 4{N-[(6RS)-2-Methyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl]-N-(prop-2-ynyl)amino}benzoic acid
07/31/2007US7250412 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation
07/26/2007WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
07/26/2007US20070173641 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility
07/26/2007US20070173515 Delta opioid receptor agonist compounds
07/26/2007US20070173511 Cyclohexyl sulfonamide derivatives
07/26/2007CA2637449A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
07/25/2007EP1810970A1 Therapeutic piperazine compounds
07/25/2007EP1370265B1 Hiv inhibiting pyrazinone derivatives
07/25/2007EP1355873B1 Pleuromutilin derivatives with antimicrobial activity
07/25/2007EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands
07/25/2007CN101006075A Bisarylurea derivatives useful for inhibiting CHK1
07/25/2007CN101005842A Modulators of muscarinic receptors
07/25/2007CN101005835A 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diab
07/25/2007CN101003516A Dentritic pattern compound, preparation method and application
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/24/2007US7247724 Method for the production of phenylalanine derivatives
07/24/2007US7247637 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life
07/24/2007US7247636 Phenolic guanidine sodium channel blockers
07/24/2007US7247633 Pyrimidine compounds and their use
07/24/2007US7247629 Antitumoral analogs of et-743
07/19/2007WO2007080140A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
07/19/2007US20070167626 Electron transport compound and organic light emitting device comprising the same
07/19/2007US20070167458 Tetrahydro-naphthalene and urea derivatives
07/19/2007US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder
07/19/2007US20070167444 Benzamide derivative or salt thereof
07/19/2007US20070167436 Cyclohexyl piperazinyl methanone derivatives
07/19/2007CA2635719A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
07/18/2007EP1808438A2 Purification and stabilization of peptide and proteins in pharmaceutical agents
07/18/2007EP1807393A1 Diarylsulfones as 5-ht2a antagonists
07/18/2007EP1711184B1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/18/2007EP1453514B1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
07/18/2007EP1403250B1 Bis(5-aryl-2-pyridyl) derivative
07/18/2007CN1326842C Electrode-active material and electrodes made by using the same, and cells equipped with the electrodes
07/18/2007CN101001840A Therapeutic compounds: pyridine as scaffold
07/18/2007CN100999502A Process of selective synthesizing 5-methyl pyrazine-2-carboxylic acid using 2,5-dimethyl pyrazine
07/18/2007CN100999501A Process for the preparation of 2-methyl piperazine derivatives
07/17/2007US7245073 Quinoxaline derivatives, and light emitting element using thereof
07/17/2007US7244843 Modulators of serotonin receptors
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone
07/12/2007WO2007077543A2 Sigma-2 receptor, method of screening of specific ligands and use of the same in diagnostic or therapeutic methods
07/12/2007WO2007077247A1 Piperazine compounds with a herbicidal action
07/12/2007WO2007077201A1 Piperazine compounds with a herbicidal action
07/12/2007WO2007021991A3 Melanocortin receptor-specific piperazine and keto-piperazine compounds
07/12/2007WO2004112687A3 Antiviral acylguanidine compounds and methods
07/12/2007US20070161793 Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative
07/12/2007US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders
07/12/2007US20070161635 Kinase inhibitors
07/12/2007CA2634195A1 Piperazine compounds with a herbicidal action
07/12/2007CA2633483A1 Piperazine compounds with a herbicidal action
07/11/2007EP1805150A2 Heterocyclical chromophore architectures
07/11/2007EP1805149A2 Heterocyclical anti-aromatic chromophore architectures
07/11/2007EP1805144A1 Heterocyclical chromophore architectures
07/11/2007EP1805141A1 Piperidines and related compounds for treatment of alzheimer's disease
07/11/2007EP1805132A2 Novel compounds
07/11/2007EP1804582A1 Polymorphic forms of tadalafil
07/11/2007CN1997645A Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
07/11/2007CN1997641A Diarylamine derivatives as calcium channel blockers
07/11/2007CN1995038A Preparation method of ziprasidone
07/11/2007CN1325481C Novel indolenium squaraine cyanine dye containing quinazolinone structure
07/10/2007US7241892 Hemisynthetic method and new compounds
07/10/2007US7241889 2-Amino-5-formyl-substituted, e.g., 2-[p-(cyclopropylaminocarbonyl)phenyl]-5-formyl-8-isopentyl--7-methyl-5,6,7,8-tetrahydropteridine; antiproliferative agents
07/10/2007US7241883 Functionalized compositions for improved immobilization
07/10/2007US7241766 Methods of using phenolic guanidine sodium channel blockers
07/10/2007US7241764 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
07/05/2007WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
07/05/2007US20070155790 Meta-benzamidine derivatives as serine protease inhibitors
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155731 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
07/05/2007US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007US20070155670 Pyrrolidine Melanocortin-Specific Compounds
07/05/2007US20070154898 Multiplexing methods using dark quenchers, nonfluorescing disazo dyes, functionalized for their rapid attachment to probe components; engineered to have a desired light absorption profile; facilitate interaction between quencher and fluorophore without form nucleic acid secondary structure
07/04/2007EP1373226B1 Process for the enhancement of cycle life of a zinc-chromium based catalyst in the synthesis of 2-methylpyrazine
07/04/2007CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
07/04/2007CN1990471A Mch antagonists and their use in the treatment of obesity
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1324006C Beta-amino acid nitrile derivs.
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
07/03/2007US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 187